Researcher profile

Kelly C. Iarosz

Kelly C. Iarosz contributes to research discovery and scholarly infrastructure.

ResearcherAffiliation not importedOpen to collaborate

Trust snapshot

Quick read

Trust 13 - UnverifiedVerification L1Unclaimed author
2works
0followers
6topics
4close collaborators

Actions

Decide how to stay connected

Follow researcher0

Identity and collaboration

How to connect with this researcher

Claiming links this public author record to a researcher profile and unlocks direct collaboration workflows.

Log in to claim

Direct collaboration

Open a focused conversation when the fit is right

Claim this author entity first to unlock direct invitations.

Research graph

See the researcher in context

Open full explorer

Inspect adjacent work, topics, institutions and collaborators without jumping out to a separate graph page.

Building this graph slice

BZPEER is loading the nearby papers, people, topics and institutions for this page.

Published work

2 published item(s)

preprint2022arXiv

Effect of two vaccine doses in the SEIR epidemic model using a stochastic cellular automaton

In this work, to support decision making of immunisation strategies, we propose the inclusion of two vaccination doses in the SEIR model considering a stochastic cellular automaton. We analyse three different scenarios of vaccination: $i) unlimited doses, (ii) limited doses into susceptible individuals, and (iii) limited doses randomly distributed overall individuals. Our results suggest that the number of vaccinations and time to start the vaccination is more relevant than the vaccine efficacy, delay between the first and second doses, and delay between vaccinated groups. The scenario (i) shows that the solution can converge early to a disease-free equilibrium for a fraction of individuals vaccinated with the first dose. In the scenario (ii), few two vaccination doses divided into a small number of applications reduce the number of infected people more than into many applications. In addition, there is a low waste of doses for the first application and an increase of the waste in the second dose. The scenario (iii) presents an increase in the waste of doses from the first to second applications more than the scenario $(ii)$. In the scenario (iii), the total of wasted doses increases linearly with the number of applications. Furthermore, the number of effective doses in the application of consecutive groups decays exponentially overtime.

preprint2019arXiv

Network properties of healthy and Alzheimer's brains

Small-world structures are often used to describe structural connections in the brain. In this work, we compare the structural connection of cortical areas of a healthy brain and a brain affected by Alzheimer's disease with artificial small-world networks. Based on statistics analysis, we demonstrate that similar small-world networks can be constructed using Newman-Watts procedure. The network quantifiers of both structural matrices are identified inside the probabilistic valley. Despite of similarities between structural connection matrices and sampled small-world networks, increased assortativity can be found in the Alzheimer brain. Our results indicate that network quantifiers can be helpful to identify abnormalities in real structural connection matrices.